Member Info for Theanalyzer

I think we will need to be patient but I am confident that Zenakine will drive Sbtx shares to new heights over time.

It will take industry time to formulate, manufacture, design new marketing and launch into wholesale and retail markets and then reorder but it will come.

Silverlight

There is a placing coming, provided share price stays over 5 pence nominal value.

Auditors raised a material uncertainty over going concern in accounts, so it’s pretty much nailed on.

Tick

I think you be able to sell Nil paid rights shares in market like fully paid share, the buyer will have to paid cash to exercise the right or lose money. They will have a separate ticker. I will be buying mine.

TwoGoodToDie

Your forecasting ability is very poor

It’s Tuesday 8th today not the 9th

Some key events for Nuburu

Golden Rule approval must be imminent

AGM on 9 July including permission to increase authorised share capital by 650 million shares to 900 million shares

AGM on 9 July also requests permission to shift domicile to Nevada where no shareholder approval is required for reverse stock splits and requests permission to undertake reverse stock splits if needed for compliance with listing rules. Also requires permission to issue up to $100 million in non public offerings at 30% discount to listed stock price.

Share reorganisations are common amongst low cap AIM and Main Market Companies when share prices drops below nominal value.

Sir Hector

5 pence is the nominal price per share.

If price drops below that then they will need a share reorganisation in order to issue shares

If Total Carbide is sold for £1.5 million that about six months losses.

Total Carbide sale would also remove invoice discounting facility and worsen cash position.

A big element of the improved result is due to lower depreciation charge down from £168,000 to £80,000 due to large asset impairment charge taken at year end.

A Total Carbide sale isn’t going to save Versarien just delay its end in my view.

TrevorBrooking

Good point

Odd that Supply didn’t give update on status of audit two months on from 30 April deadline or any other business update.

Perhaps 2024 accounts will appear this coming week.

Then we might get update on White Label IM project progress.

Nuburu Finances tight says TwoGoodToDie

Cash $70,937.

Shareholder deficit circa $39 million.

The pump for the next placing had started.

I expect to see a few more over the next week, followed by placing using remaining share authority of around 1.5 billion shares.

Then announcement of new General Meeting to increase authorised share capital to permit further fund raise at end of month.

In background Versarien will be desperate trying to sell Total Carbide and the other actions it set out in interim results.

Casapinos

The rights issue is fully underwritten so Chesnara will definitely get the rights issue cash.

As Chesnara highlight they should be able to save a lot of costs from Chesnara’s outsourcing arrangements, some capital synergies when a Part VII transfer occurs and a couple of other points. Given Chesnara have successfully merged other insurance companies they have the experience and expertise to get the work done.

For HSBC they exit what for them an effectively a tiny business which they don’t even bother announcing.

A Singer Capital Markets broker note is due but timing is down to Singer.

I suspect it won’t emerge until after year end trading up in late July / early August once new team have completed the year end financial statements ready for audit.

SA said he wasn’t going commit to hard deadline going forward because of reactions of some shareholders.

TwoGoodToDie and Hughesz talk about SYME business prospering with inventory monetisation assuming Nuburu is able to buy Tekne, still a number of key steps even after Golden Power approval.

They ignore the fact that Supply still has no inventory monetisation funding partner.

They also ignore the low share conversion price for Nuburu loans and its warrants which will likely cap Supply’s share price in near future in their fantasy of what their shares might be worth.

You have the right but not obligation to buy new shares at the lower rights issue price.

You might also be able to sell that right in the market for some cash.

I will be taking up my rights shares.

Having another open block of business In UK would change Chesnara’s dynamics and it would become more like Phoenix.

If this deal proceeds it also opens up more opportunities for Chesnara due to increased scale of group.

VRS has been in the Graphene business since 2010

Cumulative retained loses since then are circa £45 million.

Graphene revenues remain minimal and the Graphene segment remains loss making.

How patient should markets be?

Versarien may get yet another placing away but it remains an univestable company because progress on growing revenues is too slow and thus shareholders face constant dilution to fund ongoing losses.

At a market cap of circa £1 million it has to give away huge proportions of the company just to fund a few months losses.

It was also technically insolvent at end of March.

Shy chap

Except Croda does mention sleep qualities and duration under Zenakine TM tab.

Odd that you didn’t spot that.

Graphene sales barely up but Graphene segment margins down and losses up.

Total Carbide still not sold.

Strategic investor appears to be a Chinese company facing issues over investing.

Cash runway lasts only until August!

Leonard Curtis, an insolvency firm, now advising the Board on yet another restructuring.

Grim for shareholders.